+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluarix"

Quadrivalent Market Report 2025 - Product Thumbnail Image

Quadrivalent Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Fluarix is a vaccine used to protect against influenza, commonly known as the flu. It is a trivalent inactivated vaccine, meaning it contains three different strains of the influenza virus that have been killed. It is administered as an intramuscular injection and is approved for use in adults and children aged three years and older. The vaccine is designed to protect against the most common strains of the virus, and is typically administered annually. Fluarix is produced by a number of pharmaceutical companies, including GlaxoSmithKline, Sanofi Pasteur, and Seqirus. It is available in many countries around the world, and is widely used in the prevention of influenza. It is also used in combination with other vaccines, such as the pneumococcal vaccine, to provide additional protection against other illnesses. Show Less Read more